I agree that this site is using cookies. You can find further informations here.
X
Rajkumar, Vincent
899  results:
Search for persons X
?
1

Correction: Value of bone marrow examination in determining..:

Claveau, Jean-Sébastien ; Murray, David L. ; Dispenzieri, Angela...
Leukemia.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

Association of Thrombocytopenia With Disease Burden, High-R..:

Charalampous, Charalampos ; Goel, Utkarsh ; Kapoor, Prashant...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

OA-16 The rs9344 G risk allele upregulates CCND1 expression..:

Tang, Hongwei ; Yan, Huihuang ; Shivaram, Suganti...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S10 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P-281 Comparison of daratumumab-based regimens as second-li..:

Charalampous, Charalampos ; Goel, Utkarsh ; Kapoor, Prashant...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S191 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P-448 Impact of molecular cytogenetic abnormalities on the ..:

Yadav, Udit ; Kumar, Shaji ; Dispenzieri, Angela...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S287 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P921: ARTIFICIAL INTELLIGENCE BASED FDG PET/CT RADIOMICS FO..:

Shreve, Jacob ; Charalampous, Charalampos ; Warsame, Rahma...
HemaSphere.  7 (2023)  S3 - p. e156011e , 2023
Link: https://doi.org/10.1097/..
 
?
7

P-093 Solitary plasmacytoma: single institution experience ..:

Charalampous, Charalampos ; Claveau, Jean-Sebastien ; Kapoor, Prashant...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S85-S86 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P885: SOLITARY PLASMACYTOMA: SINGLE INSTITUTION EXPERIENCE ..:

Charalampous, Charalampos ; Claveau, Jean-Sebastien ; Kapoor, Prashant...
HemaSphere.  7 (2023)  S3 - p. e81981ce , 2023
Link: https://doi.org/10.1097/..
 
?
9

P-261 Comparison of different cutoffs of time from last dru..:

Goel, Utkarsh ; Charalampous, Charalampos ; Kapoor, Prashant...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S179-S180 , 2023
Link: https://doi.org/10.1016/..
 
?
10

P975: THREE-DIMENSIONAL TELOMERE PROFILING PREDICTS RISK OF..:

Kumar, Shaji ; Rajkumar, Vincent ; Jevremovic, Dragan...
HemaSphere.  7 (2023)  S3 - p. e07945f9 , 2023
Link: https://doi.org/10.1097/..
 
?
11

P-110 Ixazomib maintenance in transplant-ineligible patient..:

Dimopoulos, Meletios ; Chng, Wee Joo ; Iida, Shinsuke...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S95 , 2023
Link: https://doi.org/10.1016/..
 
?
12

P-262 Retreatment with previously refractory drugs in multi..:

Goel, Utkarsh ; Charalampous, Charalampos ; Kapoor, Prashant...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S180 , 2023
Link: https://doi.org/10.1016/..
 
?
13

P812: PREDICTING HIGH-RISK DISEASE BIOLOGY USING ARTIFICIAL..:

Shreve, Jacob ; Charalampous, Charalampos ; Kourelis, Taxiarchis...
HemaSphere.  7 (2023)  S3 - p. e0586106 , 2023
Link: https://doi.org/10.1097/..
 
?
14

Relationship among three common hematological premalignant ..:

Boddicker, Nicholas J. ; Parikh, Sameer A. ; Norman, Aaron D....
Leukemia.  37 (2023)  8 - p. 1719-1722 , 2023
Link: https://doi.org/10.1038/..
 
?
15

P-126 Adding value of serum-free light chain in assessing r..:

Askari, Elham ; Rajkumar, Vincent ; Murray, David...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S104-S105 , 2023
Link: https://doi.org/10.1016/..
 
1-15